Area of research
Genetics · Hematology
Research interest
Research interests include Medicine, Hemoglobin, Life expectancy, Population, Placebo, and Anemia.
Real-world effectiveness of voxelotor for treating sickle cell disease in the US: a large claims data analysis
Voxelotor in adolescents and adults with sickle cell disease (HOPE): long-term follow-up results of an international, randomised, double-blind, placebo-controlled, phase 3 trial
Low hemoglobin increases risk for cerebrovascular disease, kidney disease, pulmonary vasculopathy, and mortality in sickle cell disease: A systematic literature review and meta-analysis
Higher Hemoglobin Levels Achieved with Voxelotor Are Associated with Lower Vaso-occlusive Crisis Incidence: 72-Week Analysis from the HOPE Study
Estimated Life Expectancy and Income of Patients With Sickle Cell Disease Compared With Those Without Sickle Cell Disease
Opioid utilization patterns in United States individuals with sickle cell disease